328 related articles for article (PubMed ID: 19129348)
1. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
Lee MS; Smith SD; Galor A; Hoffman GS
Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.
Nesher G; Berkun Y; Mates M; Baras M; Rubinow A; Sonnenblick M
Arthritis Rheum; 2004 Apr; 50(4):1332-7. PubMed ID: 15077317
[TBL] [Abstract][Full Text] [Related]
4. The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.
Lopez-Diaz MJ; Llorca J; Gonzalez-Juanatey C; Peña-Sagredo JL; Martin J; Gonzalez-Gay MA
Semin Arthritis Rheum; 2008 Oct; 38(2):116-23. PubMed ID: 18221984
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Della Bella C; Cimino L; Macchioni P; Formisano D; Bajocchi G; Pipitone N; Catanoso MG; Restuccia G; Ghinoi A; Boiardi L
Rheumatology (Oxford); 2009 Mar; 48(3):250-3. PubMed ID: 19109317
[TBL] [Abstract][Full Text] [Related]
6. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.
Cid MC; Font C; Oristrell J; de la Sierra A; Coll-Vinent B; López-Soto A; Vilaseca J; Urbano-Márquez A; Grau JM
Arthritis Rheum; 1998 Jan; 41(1):26-32. PubMed ID: 9433866
[TBL] [Abstract][Full Text] [Related]
7. Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack.
McCabe DJ; Harrison P; Sidhu PS; Brown MM; Machin SJ
Br J Haematol; 2004 Sep; 126(6):861-9. PubMed ID: 15352991
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.
Salvarani C; Cimino L; Macchioni P; Consonni D; Cantini F; Bajocchi G; Pipitone N; Catanoso MG; Boiardi L
Arthritis Rheum; 2005 Apr; 53(2):293-7. PubMed ID: 15818722
[TBL] [Abstract][Full Text] [Related]
9. Variable platelet response to aspirin in patients with ischemic stroke.
Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
[TBL] [Abstract][Full Text] [Related]
10. Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.
Karepov V; Tolpina G; Kuliczkowski W; Serebruany V
Cerebrovasc Dis; 2008; 26(3):272-6. PubMed ID: 18648200
[TBL] [Abstract][Full Text] [Related]
11. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.
Schwammenthal Y; Tsabari R; Shenkman B; Schwartz R; Matetzky S; Lubetsky A; Orion D; Israeli-Korn S; Chapman J; Savion N; Varon D; Tanne D
Cerebrovasc Dis; 2008; 25(4):355-61. PubMed ID: 18305387
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for severe cranial ischaemic events in patients with giant cell arteritis.
Grossman C; Barshack I; Koren-Morag N; Ben-Zvi I; Bornstein G
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):88-93. PubMed ID: 28466802
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytosis in temporal arteritis rising platelet counts: a red flag for giant cell arteritis.
Lincoff NS; Erlich PD; Brass LS
J Neuroophthalmol; 2000 Jun; 20(2):67-72. PubMed ID: 10870916
[TBL] [Abstract][Full Text] [Related]
14. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis.
Salvarani C; Casali B; Farnetti E; Pipitone N; Formisano D; Nicoli D; Macchioni P; Cimino L; Bajocchi G; Grazia Catanoso M; Restuccia G; Ghinoi A; Boiardi L
Arthritis Rheum; 2007 Oct; 56(10):3502-8. PubMed ID: 17907177
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.
Lozano E; Segarra M; Corbera-Bellalta M; García-Martínez A; Espígol-Frigolé G; Plà-Campo A; Hernández-Rodríguez J; Cid MC
Ann Rheum Dis; 2010 Feb; 69(2):434-42. PubMed ID: 19289383
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for severe cranial ischaemic complications in giant cell arteritis.
Hočevar A; Ješe R; Tomšič M; Rotar Ž
Rheumatology (Oxford); 2020 Oct; 59(10):2953-2959. PubMed ID: 32125431
[TBL] [Abstract][Full Text] [Related]
17. Giant cell arteritis as a cause of first-ever stroke.
Wiszniewska M; Devuyst G; Bogousslavsky J
Cerebrovasc Dis; 2007; 24(2-3):226-30. PubMed ID: 17630482
[TBL] [Abstract][Full Text] [Related]
18. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis.
Parikh M; Miller NR; Lee AG; Savino PJ; Vacarezza MN; Cornblath W; Eggenberger E; Antonio-Santos A; Golnik K; Kardon R; Wall M
Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778
[TBL] [Abstract][Full Text] [Related]
20. [Temporal arteritis: treatment controversies].
Balsalobre Aznar J; Porta-Etessam J
Neurologia; 2010 Sep; 25(7):453-8. PubMed ID: 20964992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
